BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33574944)

  • 1. Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker.
    Mo XC; Zhang ZT; Song MJ; Zhou ZQ; Zeng JX; Du YF; Sun FZ; Yang JY; He JY; Huang Y; Xia JC; Weng DS
    Oncol Lett; 2021 Mar; 21(3):205. PubMed ID: 33574944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes associated with bladder cancer using bioinformatic analyses.
    Zheng W; Zhao Y; Wang T; Zhao X; Tan Z
    Transl Cancer Res; 2022 May; 11(5):1330-1343. PubMed ID: 35706790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis.
    Deng JL; Xu YH; Wang G
    Front Genet; 2019; 10():695. PubMed ID: 31428132
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zeng XC; Zhang L; Liao WJ; Ao L; Lin ZM; Kang W; Chen WN; Lin X
    Front Genet; 2020; 11():555537. PubMed ID: 33193629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes associated with esophageal cancer progression using bioinformatics analysis.
    Li J; Xie Y; Wang X; Jiang C; Yuan X; Zhang A; Yang L; Liu C; Zou H; Li F; Hu J
    Oncol Lett; 2020 Nov; 20(5):214. PubMed ID: 32963620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Seven Cell Cycle-Related Genes with Unfavorable Prognosis and Construction of their TF-miRNA-mRNA regulatory network in Breast Cancer.
    Hong Z; Wang Q; Hong C; Liu M; Qiu P; Lin R; Lin X; Chen F; Li Q; Liu L; Wang C; Chen D
    J Cancer; 2021; 12(3):740-753. PubMed ID: 33403032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of Fibroblast Growth Factor Receptor (FGFR) Family Genes in Breast Cancer by Integrating Online Databases and Bioinformatics.
    Zhou Z; Wu B; Tang X; Ke R; Zou Q
    Med Sci Monit; 2020 May; 26():e923517. PubMed ID: 32381997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways.
    Fei H; Chen S; Xu C
    J Ovarian Res; 2020 Jul; 13(1):82. PubMed ID: 32693821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of candidate biomarkers correlated with the pathogenesis and prognosis of breast cancer via integrated bioinformatics analysis.
    Liu S; Liu X; Wu J; Zhou W; Ni M; Meng Z; Jia S; Zhang J; Guo S; Lu S; Li Y
    Medicine (Baltimore); 2020 Dec; 99(49):e23153. PubMed ID: 33285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of core genes for serous ovarian adenocarcinoma via bioinformatics analysis.
    Zhu R; Xue J; Chen H; Zhang Q
    Oncol Lett; 2020 Nov; 20(5):145. PubMed ID: 32934713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and identification of key biomarkers in bladder carcinoma: Evidence from bioinformatics analysis.
    Yan M; Jing X; Liu Y; Cui X
    Oncol Lett; 2018 Sep; 16(3):3092-3100. PubMed ID: 30127900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
    Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
    Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.